Accretion Pharmaceuticals Stock Soars 17% on Record-Breaking H2 Results
Key Points
- Accretion Pharmaceuticals saw a 17.3% stock surge and 187% p...
Well folks, it looks like someone in the pharma world just hit the jackpot without having to manufacture a single miracle hair growth formula! Accretion Pharmaceuticals Limited just dropped their H2 FY25 numbers, and they're enough to make your portfolio's heart skip a beat - in a good way, of course.
Pills, Thrills, and Dollar Bills Picture this: a 17.3% stock price surge in a single day on the NSE, backed by a jaw-dropping 187% year-over-year profit growth. That's not a typo, and no, their accountants haven't been sampling the product line. The company posted a whopping Rs. 38.8 crores ...
While we have taken every measure to build an AI pipeline that generates credible and accuracte news, we still encourage you to conduct your own research before making investment decisions. InsAIght's content should not be considered professional financial or trading advice.